MedPath

湖北蝴蝶兰药业有限公司

Ownership
-
Established
2023-07-06
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Rizatriptan Monobenzoate Tablets

Product Name
欧立停
Approval Number
国药准字H20080740
Approval Date
Jun 21, 2023
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H42020507
Approval Date
Sep 3, 2020
NMPA

Ibuprofen Tablets

Product Name
布洛芬片
Approval Number
国药准字H42020506
Approval Date
Sep 3, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.